ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,370.00
+170.00 (2.07%)
At close: Feb 27, 2026
49.46%
Market Cap 620.76B
Revenue (ttm) 715.75M
Net Income (ttm) -20.52B
Shares Out 74.17M
EPS (ttm) -306.31
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 348,171
Average Volume 690,565
Open 8,300.00
Previous Close 8,200.00
Day's Range 8,100.00 - 8,500.00
52-Week Range 4,455.00 - 16,110.00
Beta n/a
RSI 31.53
Earnings Date n/a

About ImmuneOncia Therapeutics

ImmuneOncia Therapeutics, Inc., an immuno-oncology-centric biopharmaceutical company, develops immuno-oncology drugs for the treatment of cancer. It develops IMC-001, a human monoclonal antibody of the IgG1 type that targets PD-L1 an immunotherapy for cancer, which is in Phase II clinical trial for the treatment of NK/T cell lymphoma and solid cancer patients with high tumor mutation burden; and IMC-002, a human monoclonal antibody of the IgG4 type targeting human CD47, which is in Phase I a clinical trial for the treatment of solid cancers, su... [Read more]

Industry Pharmaceutical Preparations
Founded 2016
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 424870
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.